3:00 PM                Registration

4:00 - 4:30            Welcome and Overview of Program

Phyllis Tien, MD; Kenneth E. Sherman, MD, PhD 

Session 1            HIV and Liver Disease: The Evolving Landscape

Moderator: Kenneth Sherman, MD, PhD 

4:30 – 5:00            Breaking News in HIV

John Brooks, MD 

5:00 – 5:30            Hot Topics in Liver Disease in 2025: HIV Considerations

Phyllis Tien, MD

5:30 – 6:00            NIH Goals and Opportunities

Josh Radke, PhD

6:00 – 6:30            ESI Abstract: Higher Plasma Kynurenine - Tryptophan Ratio Predicts Incident Hepatic                                            Fibrosis in Women with HIV

Maria Duarte, MD, MAS

6:30 – 6:45            Panel Discussion

Phyllis Tien, MD; Josh Radke, PhD

6:45 – 7:00            Break

7:00 – 9:00            Poster Reception (all poster presenters at posters)

Friday, September 26
(agenda subject to change)

7:30 - 9:00 AM      Continental Breakfast

Session 2             Emerging Issues in Metabolic Dysfunction Associated Steatotic Liver Disease in HIV

Moderator:  Phyllis Tien, MD 

8:00 - 8:30             Steatotic Liver Disease: What does it mean for PWH?

Jennifer Price, MD, PhD

8:30 – 9:00            Adipocyte Function and MASLD

Jordan Lake, MD, MSc

9:00 – 9:30            Noninvasive Testing to Guide Therapy for Liver Disease

Richard Sterling, MD, MSc

9:30 - 9:45            ESI Abstract: Predictors of Incident Hepatic Fibrosis and Steatotic Liver Disease -
                             Associated Fibrosis Among Women with and without HIV

Maria Duarte, MD, MAS

9:45 - 10:00          ESI Abstract: Radiographic Findings of Steatotic Liver Disease are Associated with
                             Increased Risk of End-Stage Liver Disease Among People With and Without HIV Infection

Jessie Torgersen, MD, MHS, MSCE

10:00 - 10:15        Panel Discussion

Jennifer Price, MD, PhD; Jordan Lake, MD, MSc; Richard Sterling, MD, MSc

10:15 - 10:45        Break

Session 3            Advances in HBV Pathogenesis, Prevention, and Treatment

Moderator: David Thomas, MD, MPH

10:45 – 11:15        HBV DNA Reservoirs and Achieving HBV Cure

Ashwin Balagopal, MD

11:15 – 11:45        Immune and Non-Immune Targets of HBV:                                                                                                               Does Single or Combination Therapy Make Sense?

Shyamasundaran Kottilil, MD, PhD

11:45 – 12:15       HBV Prevention: Optimizing Primary and Secondary Vaccine Strategies

Kenneth E. Sherman, MD, PhD

12:15 – 12:30       Trainee Abstract: Effect of HCV Clearance on Immunosenescence in HIV/HCV Coinfection:                                   Evaluating Changes in Senescence-Associated Secretory Phenotype (SASP) Biomarkers

Alexandra Willauer, MD

12:30 – 12:45       Panel Discussion 

Ashwin Balagopal, MD; Shyam Kottilil, MD, PhD; Kenneth E. Sherman, MD, PhD

12:45 – 1:15         Break   

1:15 – 2:15           Lunch Discussion sponsored by Madrigal Pharmaceuticals
                             Clinical Deep Dive: Unlocking the Treatment Potential of Rezdiffra

Pierre Gholam, MD - University Hospitals Cleveland Medical Center

6:30 - 8:30            Faculty Dinner (Invite Only)

Saturday, September 27
(agenda subject to change)

7:30 - 9:00 AM      Continental Breakfast

Session 4           Emerging Issues in Viral Hepatitis and Liver Fibrosis

Phyllis Tien, MD

8:00 - 8:30            HCV Prevention and Long-Acting Therapies

David Thomas, MD, MPH

8:30 - 9:00            Updates in Hepatitis E Virus

Kenneth E. Sherman, MD, PhD

9:00 - 9:30            Omic Approaches to Understanding Liver Fibrosis

Brad E Aouizerat, MS, PhD

9:30 - 9:45            Trainee Abstract: The Last Mile: Understanding Barriers to Hepatitis C Virus (HCV) Micro-                                     Elimination among People with HIV (PWH) in San Francisco, 2021-2024

Grace Haser, MD

9:45 - 10:00          Abstract: The Gut Microbiome Links Bacterial Amino Acid Synthesis to Hepatic Steatosis in                                   People with HIV

Curtis Gabriel, MD, PhD

10:00 - 10:15        Panel Discussion

David Thomas, MD, MPH; Kenneth E. Sherman, MD, PhD; Brad E Aouizerat, MS, PhD

10:15 - 10:45        Break

Session 5             Trends in Alcohol, Drugs, and Polysubstance Use and Impacts on HIV and Viral                                            Hepatitis Infections

Moderator: David Thomas, MD, MPH

10:45 - 11:15         Unhealthy Alcohol Use Among Patients in HIV: Can We Change the Outcome?

Judy Hahn, PhD, MA

11:15 - 11:45         Emerging Issues in Substance Use in the US: Impacts on HIV and Viral Hepatitis

Kim Page, PhD, MPH, MS

11:45 - 12:15         Managing the Opioid Epidemic

Glenn Treisman, MD, PhD

12:15 - 12:30         Panel Discussion 

Judy Hahn, PhD, MA; Kim Page, PhD, MPH, MS

Session 6            Research Agenda - Plans for the Next Two Years

Moderator: Kenneth E. Sherman, MD, PhD

12:30 - 1:00          Summary of Key Research Agenda/Plans for the Next 2 Years

Phyllis Tien, MD

1:00 - 1:15            Conference Wrap-Up and Boxed Lunch To-Go

Phyllis Tien, MD

6:00 - 8:00            All Attendee Dinner